Titre : Imagerie tridimensionnelle

Imagerie tridimensionnelle : Questions médicales fréquentes

Termes MeSH sélectionnés :

Developed Countries
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Imagerie tridimensionnelle : Questions médicales les plus fréquentes", "headline": "Imagerie tridimensionnelle : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Imagerie tridimensionnelle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-18", "dateModified": "2025-05-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Imagerie tridimensionnelle" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Traitement d'image par ordinateur", "url": "https://questionsmedicales.fr/mesh/D007091", "about": { "@type": "MedicalCondition", "name": "Traitement d'image par ordinateur", "code": { "@type": "MedicalCode", "code": "D007091", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "L01.224.308" } } }, "about": { "@type": "MedicalCondition", "name": "Imagerie tridimensionnelle", "alternateName": "Imaging, Three-Dimensional", "code": { "@type": "MedicalCode", "code": "D021621", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Quan Yuan", "url": "https://questionsmedicales.fr/author/Quan%20Yuan", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China." } }, { "@type": "Person", "name": "Yasashri Ranathunga", "url": "https://questionsmedicales.fr/author/Yasashri%20Ranathunga", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Wayne State University, Detroit, Michigan 48202, USA." } }, { "@type": "Person", "name": "Suk Kyoung Lee", "url": "https://questionsmedicales.fr/author/Suk%20Kyoung%20Lee", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Wayne State University, Detroit, Michigan 48202, USA." } }, { "@type": "Person", "name": "Wen Li", "url": "https://questionsmedicales.fr/author/Wen%20Li", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Wayne State University, Detroit, Michigan 48202, USA." } }, { "@type": "Person", "name": "Myungjin Cho", "url": "https://questionsmedicales.fr/author/Myungjin%20Cho", "affiliation": { "@type": "Organization", "name": "School of ICT, Robotics and Mechanical Engineering, Institute of Information and Telecommunication Convergence (IITC), Hankyong National University, 327 Chungang-ro, Anseong 17579, Kyonggi-do, Republic of Korea." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Rehabilitation Services for Young-Onset Dementia: Examples from High- and Low-Middle-Income Countries.", "datePublished": "2024-06-17", "url": "https://questionsmedicales.fr/article/38929036", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph21060790" } }, { "@type": "ScholarlyArticle", "name": "Food security definition, measures and advocacy priorities in high-income countries: a Delphi consensus study.", "datePublished": "2023-05-05", "url": "https://questionsmedicales.fr/article/37144401", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1017/S1368980023000915" } }, { "@type": "ScholarlyArticle", "name": "Barriers to cancer treatment for people experiencing socioeconomic disadvantage in high-income countries: a scoping review.", "datePublished": "2024-05-28", "url": "https://questionsmedicales.fr/article/38807237", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-024-11129-2" } }, { "@type": "ScholarlyArticle", "name": "Work like a Doc: A comparison of regulations on residents' working hours in 14 high-income countries.", "datePublished": "2023-02-18", "url": "https://questionsmedicales.fr/article/36827717", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.healthpol.2023.104753" } }, { "@type": "ScholarlyArticle", "name": "Exploring the impact of mental health conditions on vaccine uptake in high-income countries: a systematic review.", "datePublished": "2023-01-07", "url": "https://questionsmedicales.fr/article/36611145", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12888-022-04512-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Sciences de l'information", "item": "https://questionsmedicales.fr/mesh/D007254" }, { "@type": "ListItem", "position": 3, "name": "Méthodologies informatiques", "item": "https://questionsmedicales.fr/mesh/D003205" }, { "@type": "ListItem", "position": 4, "name": "Traitement d'image par ordinateur", "item": "https://questionsmedicales.fr/mesh/D007091" }, { "@type": "ListItem", "position": 5, "name": "Imagerie tridimensionnelle", "item": "https://questionsmedicales.fr/mesh/D021621" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Imagerie tridimensionnelle - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Imagerie tridimensionnelle", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Imagerie tridimensionnelle", "description": "Quels examens utilisent l'imagerie 3D ?\nComment l'imagerie 3D aide-t-elle au diagnostic ?\nL'imagerie 3D est-elle utilisée en oncologie ?\nPeut-on détecter des anomalies avec l'imagerie 3D ?\nL'imagerie 3D est-elle utile pour les fractures ?", "url": "https://questionsmedicales.fr/mesh/D021621?mesh_terms=Developed+Countries&page=8#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Imagerie tridimensionnelle", "description": "Quels symptômes peuvent nécessiter une imagerie 3D ?\nL'imagerie 3D peut-elle aider à évaluer des douleurs abdominales ?\nQuels symptômes cardiaques peuvent être évalués par imagerie 3D ?\nL'imagerie 3D est-elle utile pour les troubles respiratoires ?\nPeut-on détecter des anomalies cérébrales avec l'imagerie 3D ?", "url": "https://questionsmedicales.fr/mesh/D021621?mesh_terms=Developed+Countries&page=8#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Imagerie tridimensionnelle", "description": "L'imagerie 3D peut-elle aider à la détection précoce des maladies ?\nComment l'imagerie 3D contribue-t-elle à la prévention des cancers ?\nPeut-on utiliser l'imagerie 3D pour le dépistage ?\nL'imagerie 3D aide-t-elle à évaluer les risques cardiovasculaires ?\nPeut-on prévenir des maladies avec l'imagerie 3D ?", "url": "https://questionsmedicales.fr/mesh/D021621?mesh_terms=Developed+Countries&page=8#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Imagerie tridimensionnelle", "description": "L'imagerie 3D est-elle utilisée pour planifier des interventions chirurgicales ?\nComment l'imagerie 3D aide-t-elle en radiothérapie ?\nPeut-on utiliser l'imagerie 3D pour guider des biopsies ?\nL'imagerie 3D est-elle utile pour le suivi des traitements ?\nPeut-on utiliser l'imagerie 3D pour des traitements non invasifs ?", "url": "https://questionsmedicales.fr/mesh/D021621?mesh_terms=Developed+Countries&page=8#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Imagerie tridimensionnelle", "description": "Quelles complications peuvent survenir avec l'imagerie 3D ?\nL'imagerie 3D peut-elle causer des effets secondaires ?\nY a-t-il des risques liés à l'utilisation d'agents de contraste ?\nL'imagerie 3D peut-elle entraîner des faux positifs ?\nQuelles sont les complications possibles après une biopsie guidée par imagerie 3D ?", "url": "https://questionsmedicales.fr/mesh/D021621?mesh_terms=Developed+Countries&page=8#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Imagerie tridimensionnelle", "description": "Quels facteurs augmentent le besoin d'imagerie 3D ?\nL'âge est-il un facteur de risque pour l'imagerie 3D ?\nLe tabagisme influence-t-il le besoin d'imagerie 3D ?\nLes antécédents médicaux influencent-ils l'imagerie 3D ?\nY a-t-il des facteurs environnementaux affectant l'imagerie 3D ?", "url": "https://questionsmedicales.fr/mesh/D021621?mesh_terms=Developed+Countries&page=8#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Quels examens utilisent l'imagerie 3D ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La tomodensitométrie (CT) et l'IRM sont couramment utilisés." } }, { "@type": "Question", "name": "Comment l'imagerie 3D aide-t-elle au diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet une visualisation détaillée des organes et des tissus, facilitant le diagnostic." } }, { "@type": "Question", "name": "L'imagerie 3D est-elle utilisée en oncologie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est essentielle pour localiser et évaluer les tumeurs." } }, { "@type": "Question", "name": "Peut-on détecter des anomalies avec l'imagerie 3D ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet de détecter des anomalies structurelles avec précision." } }, { "@type": "Question", "name": "L'imagerie 3D est-elle utile pour les fractures ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à visualiser les fractures complexes et leur impact sur les tissus environnants." } }, { "@type": "Question", "name": "Quels symptômes peuvent nécessiter une imagerie 3D ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs persistantes, des anomalies visibles ou des symptômes neurologiques." } }, { "@type": "Question", "name": "L'imagerie 3D peut-elle aider à évaluer des douleurs abdominales ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet d'identifier des problèmes comme des tumeurs ou des malformations." } }, { "@type": "Question", "name": "Quels symptômes cardiaques peuvent être évalués par imagerie 3D ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs thoraciques ou des palpitations peuvent nécessiter une évaluation." } }, { "@type": "Question", "name": "L'imagerie 3D est-elle utile pour les troubles respiratoires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à visualiser les poumons et détecter des anomalies comme des nodules." } }, { "@type": "Question", "name": "Peut-on détecter des anomalies cérébrales avec l'imagerie 3D ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est efficace pour visualiser des anomalies comme des tumeurs ou des AVC." } }, { "@type": "Question", "name": "L'imagerie 3D peut-elle aider à la détection précoce des maladies ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet de détecter des maladies à un stade précoce, améliorant les chances de traitement." } }, { "@type": "Question", "name": "Comment l'imagerie 3D contribue-t-elle à la prévention des cancers ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de surveiller les patients à risque et de détecter des anomalies précoces." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie 3D pour le dépistage ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est utilisée pour le dépistage de certaines maladies comme le cancer du sein." } }, { "@type": "Question", "name": "L'imagerie 3D aide-t-elle à évaluer les risques cardiovasculaires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet d'évaluer l'état des artères et de détecter des anomalies." } }, { "@type": "Question", "name": "Peut-on prévenir des maladies avec l'imagerie 3D ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Indirectement, en permettant une détection précoce et un suivi régulier." } }, { "@type": "Question", "name": "L'imagerie 3D est-elle utilisée pour planifier des interventions chirurgicales ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet de planifier avec précision les interventions chirurgicales." } }, { "@type": "Question", "name": "Comment l'imagerie 3D aide-t-elle en radiothérapie ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet de cibler précisément les tumeurs tout en épargnant les tissus sains." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie 3D pour guider des biopsies ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à localiser précisément les zones à biopsier." } }, { "@type": "Question", "name": "L'imagerie 3D est-elle utile pour le suivi des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle permet d'évaluer l'efficacité des traitements au fil du temps." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie 3D pour des traitements non invasifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est utilisée pour des techniques comme l'ablation par radiofréquence." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'imagerie 3D ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions allergiques aux agents de contraste ou des effets secondaires liés à l'exposition." } }, { "@type": "Question", "name": "L'imagerie 3D peut-elle causer des effets secondaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, notamment des effets liés à l'exposition aux radiations en cas de CT." } }, { "@type": "Question", "name": "Y a-t-il des risques liés à l'utilisation d'agents de contraste ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réactions allergiques ou des problèmes rénaux peuvent survenir." } }, { "@type": "Question", "name": "L'imagerie 3D peut-elle entraîner des faux positifs ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies peuvent être détectées qui ne sont pas cliniquement significatives." } }, { "@type": "Question", "name": "Quelles sont les complications possibles après une biopsie guidée par imagerie 3D ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements ou des infections peuvent survenir après la procédure." } }, { "@type": "Question", "name": "Quels facteurs augmentent le besoin d'imagerie 3D ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Antécédents familiaux de maladies, symptômes persistants ou exposition à des risques environnementaux." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour l'imagerie 3D ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles de nécessiter des examens d'imagerie." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le besoin d'imagerie 3D ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il augmente le risque de maladies pulmonaires nécessitant une évaluation." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils l'imagerie 3D ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies peuvent justifier des examens d'imagerie réguliers." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux affectant l'imagerie 3D ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des substances toxiques peut augmenter le besoin d'examens." } } ] } ] }

Sources (10000 au total)

Food security definition, measures and advocacy priorities in high-income countries: a Delphi consensus study.

To establish an international consensus on the definition of food security, measures and advocacy priorities in high-income countries.... A two-round online Delphi survey with closing in March 2020 and December 2021. Consensus was set a priori at 75 %. Qualitative data were synthesised and priorities were ranked.... High-income countries.... Household food security experts in academia, government and non-government organisations who had published in the last 5 years.... Up to thirty-two participants from fourteen high-income countries responded to the Delphi with a 25 % response rate in Round 1 and a 38 % response rate in Round 2. Consensus was reached on the technic... This study furthers the conceptual understanding of the commonly used definition of food security and its constituent dimensions. Strong advocacy is needed to ensure food security monitoring, policy a...

Barriers to cancer treatment for people experiencing socioeconomic disadvantage in high-income countries: a scoping review.

Despite advances in cancer research and treatment, the burden of cancer is not evenly distributed. People experiencing socioeconomic disadvantage have higher rates of cancer, later stage at diagnoses,... We conducted a scoping review of studies examining barriers to accessing cancer treatment for populations experiencing socioeconomic disadvantage in high-income countries, searched across four biomedi... A total of 20 studies were identified. Most (n = 16) reported data from the United States, and the remaining included publications were from Canada (n = 1), Ireland (n = 1), United Kingdom (n = 1), an... This review highlights barriers to cancer treatment across multiple levels, and underscores the importance of identifying patients at risk for socioeconomic disadvantage to improve access to treatment...

Work like a Doc: A comparison of regulations on residents' working hours in 14 high-income countries.

Medical residents work long, continuous hours. Working in conditions of extreme fatigue has adverse effects on the quality and safety of care, and on residents' quality of life. Many countries have at... We aimed to review residents' work hours regulations in different countries with an emphasis on night shifts.... Standardized qualitative data on residents' working hours were collected with the assistance of experts from 14 high-income countries through a questionnaire. An international comparative analysis was... All countries reviewed limit the weekly working hours; North-American countries limit to 60-80 h, European countries limit to 48 h. In most countries, residents work 24 or 26 consecutive hours, but th... In the countries analyzed, residents still work long hours. Attempts to limit the shift length or the weekly working hours resulted in modest improvements in residents' quality of life with mixed effe...

Exploring the impact of mental health conditions on vaccine uptake in high-income countries: a systematic review.

Vaccination is an essential public health intervention to reduce morbidity and mortality from infectious diseases. Despite being at higher at risk of infectious diseases, health inequalities towards v... We searched 7 databases from 1994 to 26/03/2021. We included all studies with a relative measure of effect comparing a group with a mental health issue to a control group. All studies covering any men... From 4,069 titles, 23 eligible studies from 12 different countries were identified, focusing on adults (n = 13) or children (n = 4) with mental health issues, siblings of children with mental health i... Mental health issues were associated with considerably lower vaccine uptake in some contexts such as substance use disorder, but findings were heterogeneous overall and by age, mental health issue or ...

Increasing pneumococcal vaccine uptake in older adults: a scoping review of interventions in high-income countries.

There is low uptake of the pneumococcal vaccination in eligible older adults, even in high-income countries that offer routine and universal vaccination programs.... To systematically characterize interventions aimed at improving pneumococcal vaccine uptake in older adults.... We conducted a scoping review following PRISMA-SCr guidelines of five interdisciplinary databases: Medline-Ovid, Embase, CINAHL, PsychInfo, and Cochrane Library. Databases were searched from January 2... Our scoping review included 39 studies that summarized interventions related to pneumococcal vaccine uptake for older adults, encompassing 2,481,887 study participants (945 healthcare providers and 2,... Several promising interventions were associated with improved outcomes related to vaccine uptake, although controlled study designs are needed to determine which interventions are most effective....

Life expectancy and geographic variation in mortality: an observational comparison study of six high-income Anglophone countries.

To compare life expectancy levels and within-country geographic variation in life expectancy across six high-income Anglophone countries between 1990 and 2018.... Demographic analysis using aggregated mortality data.... Six high-income Anglophone countries (USA, UK, Canada, Australia, Ireland and New Zealand), by sex, including an analysis of subnational geographic inequality in mortality within each country.... Data come from the Human Mortality Database, the WHO Mortality Database and the vital statistics agencies of six high-income Anglophone countries.... Life expectancy at birth and age 65; age and cause of death contributions to life expectancy differences between countries; index of dissimilarity for within-country geographic variation in mortality.... Among six high-income Anglophone countries, Australia is the clear best performer in life expectancy at birth, leading its peer countries by 1.26-3.95 years for women and by 0.97-4.88 years for men in... Australia has achieved the highest life expectancy among Anglophone countries and tends to rank well in international comparisons of life expectancy overall. It serves as a potential model for lower-p...

Perioperative mortality in low-, middle-, and high-income countries: Protocol for a multi-level meta-regression analysis.

Surgery is an indispensable component of a functional healthcare system. To date there is limited information regarding how many people die during the perioperative period globally. This study describ... Published studies reporting the number of perioperative deaths from bellwether surgical procedures among adults will be identified from MEDLINE, Embase, Cochrane CENTRAL, LILACS and Global Index Medic... The systematic review and multilevel meta-regression that will be conducted based on this protocol will provide synthesized global evidence regarding the trends of perioperative mortality. This eventu... Systematic review registration: PROSPERO registration number 429040....

Vaccine clinical trials in low- and middle-income countries: a brief review of standard, newer and proposed approaches.

Vaccine clinical trials are necessary in low- and middle-income countries (LMICs) because new vaccine candidates are developed against diseases found mainly in these settings, the results of trials do... We searched PubMed and conducted a narrative review on standard, newer and proposed approaches toward obtaining data supportive for vaccine licensure, with a special focus in LMICs.... Of the vaccine trials done worldwide, only a small proportion is conducted in LMICs, but this is likely to increase as more research experience and infrastructure is developed. At present, the majorit...

Drug Prices After Patent Expirations in High-Income Countries and Implications for Cost-Effectiveness Analyses.

Understanding how patent expirations affect drug prices is crucial because price changes directly inform accurate cost-effectiveness assessments. This study investigates the association between patent... To analyze how the expiration of drug patents is associated with drug price changes and to assess the implications of these price changes for cost-effectiveness evaluations.... This cohort study performed an event study design using data from 8 high-income countries to assess the association between patent expiration and drug prices, and created a simulation model to underst... Drug patent expiration.... Change in drug prices and differences in incremental cost-effectiveness ratios when considering vs ignoring postpatent price dynamics.... The sample comprised 505 drugs undergoing patent expiration in Australia, Canada, France, Germany, Japan, Switzerland, UK, and US. Price decreases were statistically significant over the 8 years after... The findings of this cohort study demonstrate that drug prices were reduced substantially after patent expirations in high-income countries. Therefore, incorporating information on patent status and p...